Patent Yard Sign in
Canadian application, no grantCanada

Human longevity-assurance protein homologs

CA 2298766 A1 · Owner: Corley, Neil C. · Inventors: Lal, Preeti; Shah, Purvi; Corley, Neil C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides two human longevity-assurance protein homologs designated individually as LAPH-1 and LAPH-2 and collectively as LAPH and , polynucleotides which identify and encode LAPH. The invention also provides expression vectors, host cells, agonists antibodies and antagonists. The , invention also provides methods for treating disorders associated with expression of LAPH.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 28, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 28, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 28, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 28, 1998
GrantedNo grant recorded
Term endedJuly 28, 2018
Patent numberCA 2298766 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedJuly 28, 1998Term endedJuly 28, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.